iCAD Launches Revolutionary Short-term Personalized Risk Assessment Solution for 3D MammographyGlobeNewsWire • 09/29/21
iCAD to Host Educational Roundtable to Help Clinicians and Facilities Recover from COVID-19 ImpactGlobeNewsWire • 09/09/21
iCAD, Inc. (ICAD) CEO Michael Klein on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/08/21
iCAD Q2 Earnings Lag Street Estimates As Sales Impacted By Longer Enterprise Sales CyclesBenzinga • 08/06/21
Icad (ICAD) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 07/29/21
iCAD's ProFound AI for Digital Breast Tomosynthesis Version 3.0 Receives CE Mark ApprovalGlobeNewsWire • 06/14/21
iCAD Announces Educational Webinar Featuring Leading Global Experts Discussing New Multidisciplinary Approach for Treating Brain Tumors, May 25GlobeNewsWire • 05/17/21
iCAD, Inc. (ICAD) CEO Michael Klein on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 04/29/21
iCAD Shares On The Rise After FDA Approval For Third Version Of ProFound AI For 3D MammographyBenzinga • 03/16/21
New Research Supporting ProFound AI Presented at European Congress of Radiology Online MeetingGlobeNewsWire • 03/08/21